DiscoverFreakonomics Radio615. Is Ozempic as Magical as It Sounds?
615. Is Ozempic as Magical as It Sounds?

615. Is Ozempic as Magical as It Sounds?

Update: 2024-12-123
Share

Description

In a wide-ranging conversation with Ezekiel Emanuel, the policymaking physician and medical gadfly, we discuss the massive effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. We also talk about the state of cancer care, mysteries in the gut microbiome, flaws in the U.S. healthcare system — and what a second Trump term means for healthcare policy.

 

  • SOURCES:
    • Ezekiel Emanuel, vice provost for Global Initiatives, co-director of the Health Transformation Institute, and professor at the University of Pennsylvania Perelman School of Medicine.

 

 

Comments (1)

Eyal Bazelet

the best investment to reduce ibesity is educating people to have healthy eating habits. much cheaper and more effective long term.

Jan 2nd
Reply
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

615. Is Ozempic as Magical as It Sounds?

615. Is Ozempic as Magical as It Sounds?

Freakonomics Radio + Stitcher